Investing

Avalo Therapeutics : AVTX

AVTX

Stock Data

$13.71

$0.31 (2.31%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Avalo Therapeutics Inc, originally known as Avantium N.V., is a pioneer in the field of renewable chemistry based in Amsterdam, the Netherlands. Founded in 2000, the company focuses on creating sustainable chemical solutions, notably developing plant-based recyclable plastics like polyethylene furanoate (PEF). Avalo Therapeutics is also known for its innovative technologies such as Flowrence for catalyst testing, and its efforts in transforming non-food plant materials into valuable industrial sugars and lignin. Their work supports the production of eco-friendly materials, contributing to a greener future.

All Avalo Therapeutics Articles

1 Article

Lee Jackson | Apr 6, 2026 at 7:54 AM EDT

Here Are Monday’s Top Wall Street Analyst Research Calls: Avis Budget, Carvana, Dow, Kratos Defense, Netflix, Northern Trust, PayPay,Twilio, Tyson Foods and More

Pre-Market Stock Futures: Futures are trading mixed as we get ready to kick off the first-quarter earnings season next week,…